31P MRS MT Participants 1-10
Description
31P Magnetisation Transfer MRS on subjects 1-10 (aged 60+) before and after photobiomodulation treatment (670nm) Mitochondrial function declines with age and many pathological processes of neurodegenerative diseases stem from this dysfunction when mitochondria fail to produce the necessary energy required. Photobiomodulation (PBM), long-wavelength light therapy, has been shown to rescue mitochondrial function in animal models and improve human health, but clinical uptake is limited due to uncertainty around efficacy and the mechanisms responsible. Through combined theoretical Monte Carlo light modelling and practical 31P Magnetisation Transfer Magnetic Resonance Spectroscopy (MT-MRS) we quantify, for the first time, the effects of 670 nm PBM treatment on healthy aging human brains. 31P MT-MRS revealed a significant increase in the rate of ATP flux after PBM in a sample of older adults. Light modelling shows 1% absorption in grey matter and confirms absorption peaks at 670 and 820 nm. Our study provides evidence of PBM therapeutic efficacy and strengthens confidence in PBM as an acceptable healthcare technology to improve mitochondrial function and human health. Patients 1-10 Pre Photobiomodulation MRS assessment and Post Photobiomodulation MRS assessment 31P FID 31P Magnetisation Transfer Magnetic Resonance Spectroscopy (different saturation times) T2 Localizer 1H Mega Press